439 related articles for article (PubMed ID: 5003527)
1. Thoughts and questions on the role of the D u factor in Rh prophylaxis.
Eldon K
Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):454. PubMed ID: 5003527
[No Abstract] [Full Text] [Related]
2. The future of Rh immune globulin.
Gorman JG
Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
[No Abstract] [Full Text] [Related]
3. [Prophylaxis of Rh isoimmunization].
Policlinico Prat; 1968 Feb; 75(6):188-90. PubMed ID: 4191604
[No Abstract] [Full Text] [Related]
4. [Prevention and treatment of Rh. isoimmunization. Results].
Martínez M; Lozano G; Flores F; Fernández P; Garrido G
Acta Obstet Ginecol Hisp Lusit; 1971 Mar; 19(2):149-57. PubMed ID: 4996734
[No Abstract] [Full Text] [Related]
5. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
Gherardi A
Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
[No Abstract] [Full Text] [Related]
6. [Allo-immunization against antigens from non-D blood groups. Value of detection].
Mannessier L; Goudemand M; Delecour M
Lille Med; 1980 Mar; 25(3):90-3. PubMed ID: 6768941
[No Abstract] [Full Text] [Related]
7. [The present status of prevention of Rh sensitization with anti-D sera].
Preisler O; Schneider J
Geburtshilfe Frauenheilkd; 1966 May; 26(5):732-4. PubMed ID: 4956775
[No Abstract] [Full Text] [Related]
8. Some epidemiological aspects of the prevention of Rh isoimmunization.
Walker W
Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):431-5. PubMed ID: 5003520
[No Abstract] [Full Text] [Related]
9. [Modern trends in prevention of anti-Rh immunization].
Malaguzzi Valeri O
Minerva Med; 1969 Apr; 60(31):1503-4. PubMed ID: 4977456
[No Abstract] [Full Text] [Related]
10. [Selective Rh prevention in pregnancy].
Helderweirt G
Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
[No Abstract] [Full Text] [Related]
11. Ten-year experience with high titer anti-D plasma for the prevention of Rh isoimmunization.
Hamilton EG
Obstet Gynecol; 1972 Nov; 40(5):692-6. PubMed ID: 4628388
[No Abstract] [Full Text] [Related]
12. Do we need to be more concerned about weak D antigens?
Garratty G
Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
[No Abstract] [Full Text] [Related]
13. [Practical problems in prevention of Rh-sensitization with immunological methods].
Althoff W; Schellong G; Stahl M
Minerva Med; 1969 Jul; 60(59):2905-15. PubMed ID: 4978556
[No Abstract] [Full Text] [Related]
14. Current clinical concepts in hemolytic disease and blood group incompatibility.
Cherry SH
Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
[No Abstract] [Full Text] [Related]
15. [Diagnostic and therapeutic measures in materno-fetal Rh-factor isoimmunization].
Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
Arch Ostet Ginecol; 1969 Dec; 74(6):476-94. PubMed ID: 5000274
[No Abstract] [Full Text] [Related]
16. [Transfusion complications caused by rarely occurring non-D antibodies].
Orv Hetil; 1983 Feb; 124(9):545. PubMed ID: 6405339
[No Abstract] [Full Text] [Related]
17. [Actual possibilities of prevention of serologic incompatibility].
Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L
Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438
[No Abstract] [Full Text] [Related]
18. [10 years of specific prophylaxis of hemolytic disease of the newborn in Bulgaria].
Kurteva B; Doĭchinova N; Shinkov D; Angelova Ts; Ivanova L
Akush Ginekol (Sofiia); 1979; 18(3):172-9. PubMed ID: 89820
[No Abstract] [Full Text] [Related]
19. [Use of anti-D gamma globulins in the prevention of Rh isoimmunization].
Gasparri F; Massi GB; Curiel P; Cattaneo A
Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1881-4. PubMed ID: 4186556
[No Abstract] [Full Text] [Related]
20. Clinical experience with a new preparation of Rh 0 (D) immune globulin (human).
Wurzel JF; Hansen LM; Evensen KL
Obstet Gynecol; 1973 May; 41(5):760-4. PubMed ID: 4633212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
